Market closed

ResMed/$RMD

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About ResMed

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Ticker

$RMD
Sector
Health Care

Trading on

NYSE

Industry

Health Care Equipment & Supplies
Headquarters
San Diego, United States

Employees

9,980
Website
www.resmed.com

ResMed Metrics

BasicAdvanced
$34B
30.54
$7.54
0.69
$2.02
0.92%

$34B

0.69

$252.80

$168.29

726K

$2.02

2.921

1.369

15.632

16.366

26.02%

40.70%

13.27%

23.56%

30.539

7.039

6.51

18.46

25.125

0.88%

0.92%

9.88%

22.60%

12.81%

30.25%

6.74%

What the Analysts think about ResMed

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for ResMed stock.

ResMed Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

ResMed Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

ResMed News

AllArticlesVideos
Top 50 High Quality Dividend Growth Stocks - January 2025

Top 50 High Quality Dividend Growth Stocks - January 2025

Seeking Alpha·3 days ago
ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025

ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025

GlobeNewsWire·6 days ago
ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewsWire·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $RMD

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for ResMed stock?

ResMed (RMD) has a market cap of $34B as of January 15, 2025.

What is the P/E ratio for ResMed stock?

The price to earnings (P/E) ratio for ResMed (RMD) stock is 30.54 as of January 15, 2025.

Does ResMed stock pay dividends?

Yes, the ResMed (RMD) stock pays dividends to shareholders. As of January 15, 2025, the dividend rate is $2.02 and the yield is 0.92%. ResMed has a payout ratio of 26.02% on a trailing twelve-month basis.

When is the next ResMed dividend payment date?

The next ResMed (RMD) dividend payment date is unconfirmed.

What is the beta indicator for ResMed?

ResMed (RMD) has a beta rating of 0.69. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.